FAAH Availability in Psychiatric Disorders: A PET Study
Status:
Recruiting
Trial end date:
2024-08-01
Target enrollment:
Participant gender:
Summary
The aim of the present study is to examine Fatty Acid Amide Hydrolase (FAAH) availability in
humans, including healthy individuals and across a spectrum of psychiatric disorders in which
alterations in the endocannabinoid system are observed.